The price and mark up of pharmaceutical drugs supplied on the black market.

作者: Shann Hulme , Caitlin Elizabeth Hughes , Suzanne Nielsen

DOI: 10.1016/J.DRUGPO.2019.102626

关键词:

摘要: Abstract Background Research examining illicit drug markets has shown that price affects consumption and mark ups are extremely high. However, the economics of black market pharmaceutical supply remains unknown, despite increasing harms due to pharmaceuticals. Methods Semi-structured, telephone interviews were conducted in Australia with 51 people involved supplying pharmaceuticals previous six months. Interviews audio-recorded, transcribed quantitative information on costs, sale price, quantity frequency coded used calculate up ratio for each transaction ‘cycle’, accounting distribution via selling, gifting trading. Mixed effects gamma regressions identify predictors up, clustering by participant. Results There 29 drugs supplied over 111 cycles, including hypnotic-sedatives (38%), opioids (32%), stimulants (18%) others (12%). Sedatives sold at lower prices than there was a negative relationship between unit size, consistent discount effect. For every dollar spent acquiring drugs, supplier earned median $3.19. Cycles involving sourced intermediaries (e.g. friends/family) had directly from medical system. Conclusion To our knowledge, this is one few studies analyse economic aspects perspective. small number cycles realised large profits may warrant different types policy responses, however most suppliers sample gross revenue profit modest.

参考文章(56)
Jonathan P. Caulkins, Peter Reuter, What Price Data Tell Us about Drug Markets Journal of Drug Issues. ,vol. 28, pp. 593- 612 ,(1998) , 10.1177/002204269802800302
Carl C Gaither, Robert W Anthony, Andrew Cseko, Eric Schulman, Arthur Fries, The Price and Purity of Illicit Drugs: 1981-2007 ,(2008)
Thomas F. Babor, David R. Foxcroft, Jonathan P. Caulkins, Robin Room, Jürgen Rehm, Ingeborg Rossow, Benedikt Fischer, Keith Humphreys, Griffith Edwards, Peter Reuter, John Strang, Isidore S. Obot, Drug Policy and the Public Good ,(2010)
Robert J. MacCoun, Allan Abrahamse, Barbara Simon, Peter Reuter, Patrick Murphy, Money from Crime: A Study of the Economics of Drug Dealing in Washington, D.C. RAND, Drug Policy Research Center. ,(1990)
Jonathan P. Caulkins, Bruce Johnson, Angela Taylor, Lowell Taylor, What Drug Dealers Tell Us about Their Costs of Doing Business Journal of Drug Issues. ,vol. 29, pp. 323- 340 ,(1999) , 10.1177/002204269902900211
Stefan Grzybowski, Amin Sajan, Trevor Corneil, The street value of prescription drugs Canadian Medical Association Journal. ,vol. 159, pp. 139- 142 ,(1998)
Jonathan P. Caulkins, Benjamin Gurga, Christopher Little, Economic analysis of drug transaction ‘cycles’ described by incarcerated UK drug dealers Global Crime. ,vol. 10, pp. 94- 112 ,(2009) , 10.1080/17440570902783889
Peter Reuter, Mark AR Kleiman, Risks and Prices: An Economic Analysis of Drug Enforcement Crime and Justice. ,vol. 7, pp. 289- 340 ,(1986) , 10.1086/449116
Jonathan P. Caulkins, Rema Padman, Quantity Discounts and Quality Premia for Illicit Drugs Journal of the American Statistical Association. ,vol. 88, pp. 748- 757 ,(1993) , 10.1080/01621459.1993.10476335